Since Interleukin-1 blockade has proved ineffective as a sepsis treatment (Step 2c), it is difficult to understand how blocking IL-1 would prove effective for treating COVID-19 where levels appear to be lower. The gene discussed is IL1A; the disease is Sepsis.